Clinical Report: Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer

Overview

This study investigates the role of prealbumin levels as a predictive biomarker for metachronous liver metastases (MLM) in colorectal cancer (CRC) patients post-surgery. Findings suggest that low prealbumin levels are significantly associated with an increased risk of MLM, highlighting its potential utility in clinical practice.

Background

Colorectal cancer is a leading cause of cancer-related morbidity and mortality, with the liver being the most common site of metastasis. Identifying predictive factors for metachronous liver metastases is crucial for improving patient outcomes following curative surgeries. Prealbumin, an acute-phase protein, has been linked to various malignancies, but its specific association with MLM in CRC remains underexplored.

Data Highlights

No numerical data or trial data provided in the article.

Key Findings

• Low prealbumin levels are associated with a higher risk of metachronous liver metastases in CRC patients.
• The study included 627 CRC patients who underwent curative resection, with follow-up assessments for MLM.
• Prealbumin levels were measured postoperatively, with a normal range defined as 200–400 mg/L.
• Patients with prealbumin levels below the normal range exhibited significantly poorer outcomes regarding MLM.
• Findings support the use of prealbumin as a potential biomarker for assessing the risk of liver metastases in CRC patients.

Clinical Implications

Monitoring prealbumin levels in CRC patients post-surgery may provide valuable insights into the risk of developing metachronous liver metastases. This could guide clinical decision-making and follow-up strategies to improve patient management and outcomes.

Conclusion

The study underscores the importance of prealbumin as a predictive biomarker for metachronous liver metastases in colorectal cancer, warranting further investigation in clinical settings.

References

1. BMC Cancer, 2025 -- Prealbumin predicts metachronous liver metastasis in colorectal cancer
2. Springer, 2023 -- Evaluating the Role of Preoperative Hypoalbuminemia and Hypoproteinemia as Predictors of Anastomotic Leakage in Elective Colorectal Surgery within an Enhanced Recovery After Surgery (ERAS) Framework
3. Springer, 2024 -- Evaluating Complete Blood Count Parameters as Indicators of Early Metastasis to Liver and Lungs in Patients with Resected Colorectal Cancer: A Retrospective Cohort Analysis
4. Springer, 2020 -- The Prognostic Significance of the Albumin to Globulin Ratio in Patients with Non-Muscle-Invasive Bladder Cancer
5. EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases - PubMed
6. Journal of Gastrointestinal Surgery — C-Reactive Protein as a Prognostic Indicator for Anastomotic Leakage After Restorative Colorectal Surgery in an Enhanced Recovery After Surgery Framework
7. NCCN Colon Cancer Guidelines Version 2.2025
8. EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases - PubMed
9. Prealbumin predicts metachronous liver metastasis in colorectal cancer | BMC Cancer | Springer Nature Link